Paysign, Inc. (PAYS) Market Cap & Valuation Ratios
Paysign, Inc. (PAYS) has a market cap of $842.4M, a trailing P/E of 55.3 and a price-to-sales ratio of 8.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PAYSPaysign, Inc.Follow PAYS — free
—
Price chart with a free account
- Market cap
- 842.4M
- P/E TTM
- 55.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Peers
software - infrastructure · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PAYS | 0.8 | 55.3 | 6.7 | 25.3 | 8.1% | +47% | 17% | — |
| BAND | 1.4 | — | 1.9 | 32.9 | 4.7% | +9% | -2% | -3% |
| RPD | 1.0 | 48.1 | 1.4 | 21.6 | 12.8% | +0.1% | 1% | 1% |
| OSPN | 0.7 | 11.4 | 2.9 | 12.5 | 5.4% | +2% | 18% | 15% |
| YEXT | 0.7 | 41.6 | 1.8 | 12.6 | 7.3% | -1% | 8% | 41% |
| AEVA | 0.7 | — | 29.1 | — | — | +56% | — | -163% |
| CCSI | 0.7 | 7.6 | 3.2 | 6.8 | 16.8% | +1% | 42% | 23% |
| PRTH | 0.6 | 11.5 | 1.6 | 7.4 | 16.1% | +9% | 14% | 14% |
| SABR | 0.6 | — | 1.5 | 9.8 | -2.7% | +5% | 11% | 10% |
| RZLV | 0.6 | — | 15.7 | — | — | +2224% | -186% | -17% |
| BLZE | 0.5 | — | 3.0 | 54.2 | 3.0% | +14% | -11% | -34% |
| Median of these 10 | 11.5 | 2.4 | 12.6 | 6.3% | +7% | 8% | 6% |
P/E 55.3 vs. a peer median of 11.5; EV/Sales 6.7 vs. 2.4. PAYS's own P/E sits at the 63rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesBAND and AEVA and SABR and RZLV and BLZE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Paysign, Inc. — questions
- What is Paysign, Inc.'s market cap?
- $842.4M.
- What is Paysign, Inc.'s P/E ratio?
- 55.3 on trailing twelve-month earnings to 2026-06-30.
- What is Paysign, Inc.'s price-to-sales ratio?
- 8.4.
Every figure on this page comes from Paysign, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.